BeiGene
BGNE
#914
Rank
HK$169.65 B
Marketcap
HK$1,506
Share price
-0.38%
Change (1 day)
2.89%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Number of shares outstanding for BeiGene (BGNE)

Number of shares outstanding as of November 2024 : 104,698,659

According to BeiGene 's latest financial reports and stock price the company's current number of shares outstanding is 104,698,659. At the end of 2024 the company had 104,698,659 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BeiGene from 2015 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.10 B0.03%
20230.10 B0.87%
20220.10 B9.19%
202195.02 M4.6%
202090.84 M49.7%
201960.68 M2.19%
201859.38 M30.39%
201745.54 M14.78%
201639.67 M25.9%
201531.51 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
21,043,458-79.90%๐Ÿ‡บ๐Ÿ‡ธ USA
697,211,592 565.92%๐Ÿ‡บ๐Ÿ‡ธ USA